Angela S.  Lalor net worth and biography

Angela Lalor Biography and Net Worth

Director of Enovis

Angela Lalor served as Senior Vice President, Human Resources, of Danaher Corporation from 2012 until April 1, 2022, when she moved into an advisory role with Danaher until her retirement from Danaher at the end of the first quarter of 2023. Prior to her career at Danaher, Angela served at 3M for 22 years in a series of roles of progressive responsibility, including her final role as Senior Vice President of Human Resources for the company. She holds a B.A. in Psychology from University of Northern Iowa and an M.A. in Industrial Relations and Human Resources from the University of Iowa. Angela serves as Chair of the Compensation and Human Capital Management Committee of the Board.

What is Angela S. Lalor's net worth?

The estimated net worth of Angela S. Lalor is at least $950.09 thousand as of November 12th, 2026. Ms. Lalor owns 34,117 shares of Enovis stock worth more than $950,090 as of November 17th. This net worth evaluation does not reflect any other assets that Ms. Lalor may own. Learn More about Angela S. Lalor's net worth.

How do I contact Angela S. Lalor?

The corporate mailing address for Ms. Lalor and other Enovis executives is 2900 Lake Vista Drive, Suite 200, Lewisville, TX, 75067. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on Angela S. Lalor's contact information.

Has Angela S. Lalor been buying or selling shares of Enovis?

Within the last three months, Angela S. Lalor has bought $99,577.12 of Enovis stock. Most recently, on Friday, November 13th, Angela S. Lalor bought 880 shares of Enovis stock. The stock was acquired at an average cost of $28.27 per share, with a total value of $24,877.60. Following the completion of the transaction, the director now directly owns 34,997 shares of the company's stock, valued at $989,365.19. Learn More on Angela S. Lalor's trading history.

Who are Enovis' active insiders?

Enovis' insider roster includes Benjamin Berry (CFO), Oliver Engert (Insider), Christopher Hix (CFO), John Kleckner (Insider), Angela Lalor (Director), Patricia Lang (SVP), Damien Mcdonald (CEO), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO & Chairman), Rajiv Vinnakota (Director), and Sharon Wienbar (Director). Learn More on Enovis' active insiders.

Are insiders buying or selling shares of Enovis?

During the last year, Enovis insiders bought shares 23 times. They purchased a total of 42,077 shares worth more than $937,821.78. During the last year, insiders at the sold shares 2 times. They sold a total of 1,665 shares worth more than $45,294.66. The most recent insider tranaction occured on November, 13th when Director Angela S. Lalor bought 880 shares worth more than $24,877.60. Insiders at Enovis own 2.9% of the company. Learn More about insider trades at Enovis.

Information on this page was last updated on 11/13/2026.

Angela S. Lalor Insider Trading History at Enovis

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/13/2026Buy880$28.27$24,877.6034,997View SEC Filing Icon  
11/12/2026Buy874$28.04$24,506.9634,117View SEC Filing Icon  
11/11/2026Buy870$28.86$25,108.2033,243View SEC Filing Icon  
11/10/2026Buy887$28.28$25,084.3632,373View SEC Filing Icon  
See Full Table

Angela S. Lalor Buying and Selling Activity at Enovis

This chart shows Angela S. Lalor's buying and selling at Enovis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enovis Company Overview

Enovis logo
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $27.85
Low: $27.55
High: $28.37

50 Day Range

MA: $20.71
Low: $17.44
High: $28.62

2 Week Range

Now: $27.85
Low: $16.70
High: $31.67

Volume

1,258,195 shs

Average Volume

1,879,055 shs

Market Capitalization

$1.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31